20523 ⎘
Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof; Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
METHOD AND KIT FOR TREATING MICROSATELLITE-STABLE SOLID TUMORS
#2Minitablet, Preparation Method Thereof, and Formulation
#3Akkermansia muciniphila MG784 for alleviating constipation,promoting defecation, improving intestinal barrier function and intestinal immunity, and its uses
#4HUMAN ANTIBODY AGAINST CORONAVIRUS VARIANTS OR ANTIGEN-BINDING FRAGMENT THEREOF
#5UREA-LINKED 2-AMINOIMIDAZOLE DIMER POTENTIATORS
#6APPLICATION OF A COMBINATION DRUG IN THE TREATMENT OF PATHOGENIC BACTERIAL PERSISTENT INFECTIONS
#7TOPICAL FORMUATIONS AND INSTILLATES, KITS, AND METHODS FOR TREATING INTEGUMENTARY WOUNDS, AND USES THEREOF
#8METHODS OF MODULATING ATXN2 EXPRESSION
#9METHODS FOR TREATING OR PREVENTING NEUROENDOCRINE TUMOR FORMATION USING XPO1 INHIBITORS
#10COMPOUNDS AND METHODS FOR TREATING AN EPILEPTIC DISORDER
#11MODULATORS OF RAR RELATED ORPHAN RECEPTORS (RORs)
#12COMPOSITIONS INCLUDING CAFFEIC ACID PHENETHYL ESTER
#13PHARMACEUTICAL COMPOSITION AND USES THEREOF
#14COMPOSITION FOR RELIEVING SKIN ITCHING OR SKIN SOOTHING
#15PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF NEPHROPATHY AND/OR DIABETES MELLITUS, COMPRISING ENAVOGLIFLOZIN
#16NOVEL COMBINATION OF RIFAXIMIN AND CLARITHROMYCIN FOR TREATING MULTIDRUG-RESISTANT MYCOBACTERIUM ABSCESSUS
#17COMBINATION TREATMENT OF AN ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODY AND CHEMOTHERAPY
#18THERAPEUTIC COMPOSITIONS AND METHODS FOR USING SAME
#19USE OF COMBINED COMPOSITION IN PREPARING DRUG FOR RESISTING FUNGAL AND BACTERIAL INFECTIONS
#20NITAZOXANIDE FOR THE TREATMENT OF HEPATIC IMPAIRMENT
#21METAL OXIDE ENCAPSULATED DRUG COMPOSITIONS AND METHODS OF PREPARING THE SAME
#22PRODUCTION & SECRETION OF AUXIN-LIKE MOLECULES IN BACTERIA
#23PHARMACEUTICAL COMPOSITION
#242-HYDROXY-OCTADECENE-9-CIS-OATE FOR USE IN THE TREATMENT OF ONCOLOGICAL PATHOLOGIES AND NEUROPATHIC PAIN
#25ALZHEIMER-TYPE DEMENTIA SUPPRESSANT, AND METHOD FOR PRODUCING SAME
#26MACROLIDE COMPOUND AND PREPARATION METHOD AND APPLICATION THEREOF
#27COMPOSITION OF PAEONIFLORIN AND ISOLIQUIRITIGENIN AND USE THEREOF
#28COMPOSITIONS COMPRISING A SEROTONERGIC TRYPTAMINE COMPOUND
#29COMPOSITION AND FOOD SUPPLEMENTARY FOR SARCOPENIA AND PERIODONTAL DISEASES CONTAINING ALDER AND ELM COMPLEX EXTRACTS AS ACTIVE INGREDIENTS
#30Methods for Treating a Health Condition with Probiotics
#31COMPOSITIONS AND METHODS FOR THE INHIBITION OF METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS
#32Method of Treatment of SARS-CoV2 and Lewy-Body Spectrum Dementia Diseases
#33PHARMACEUTICAL COMPOSITION COMPRISING ENAVOGLIFLOZIN FOR PREVENTING OR TREATING CARDIOVASCULAR AGING DISEASES
#34PROCESSES AND COMPOSITIONS WITH ANTIBACTERIAL PROPERTIES FOR THE TREATMENT OF DEMODEX BLEPHARITIS
#35PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#36METHOD FOR IMPROVING SKIN CONDITION AND/OR RELIEVING ANEMIA BY PEACH EXTRACT
#37HEART VALVE PROSTHESES WITH A DRUG ELUTING MECHANISM
#38COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS, CHEMOTHERAPEUTIC AGENTS, AND ANTI-FIBROTIC AGENTS
#395HT AGONISTS FOR TREATING DISORDERS
#40METHODS OF TREATING CANCER WITH AN ANTI-PD-L1 ANTIBODY
#41COMPOSITIONS AND METHODS FOR TREATING ADVANCED SOLID TUMORS
#42COMBINATION TREATMENTS
#43LOW DOSE TOPIRAMATE/PHENTERMINE COMPOSITION AND METHODS OF USE THEREOF
#44NON-ACTIVATED, AMORPHOUS, pH NEUTRAL, TWO-PART BEDSIDE-READY CLAY DELIVERY SYSTEM THAT TREATS PATHOGEN INFECTIONS IN HUMANS AND ANIMALS
#45COMBINATION OF INOSITOL PHOSPHORYLCERAMIDE SYNTHETASE INHIBITOR AND AMPHOTERICIN B, AND USE THEREOF
#46Polyhomoarginine (PHA) Polymers And Uses Thereof
#47POLYMORPHS OF TRIAZOLE ANTIFUNGAL COMPOUND PC945
#48METHOD OF PREVENTING OR TREATING HEART FAILURE IN A PATIENT USING (4S)-4-(4-CYANO-2-METHOXYPHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1,6-NAPHTHYRIDINE-3-CARBOXAMIDE
#49METHODS OF ADMINISTRATION FOR HIGHLY WATER-SOLUBLE SALTS OF A SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKER
#50OVARIAN CANCER VACCINES
#51METAL CHELATING COMPOSITIONS AND METHODS FOR CONTROLLING THE GROWTH OR ACTIVITIES OF A LIVING CELL OR ORGANISM
#52PHARMACEUTICAL COMPOSITION AND USE THEREOF
#53COMPOSITION FOR REMOVING HELICOBACTER PYLORI COMPRISING ZASTAPRAZAN OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
#54METHODS AND COMPOSITIONS FOR TARGETED DELIVERY OF PROTEIN FRAGMENTS
#55VACCINE ADJUVANTS AND FORMULATIONS
#56COMPOSITIONS FOR IMPROVING GUT HEALTH AND/OR MILK PRODUCTION IN RUMINANTS, USES AND METHODS THEREOF
#57ACYLATED GLUCAGON ANALOGUES
#58PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#59METHODS FOR TREATING NEWLY DIAGNOSED MYCOBACTERIUM AVIUM COMPLEX LUNG INFECTIONS
#60METHODS OF TRANSDUCTION USING A VIRAL VECTOR AND INHIBITORS OF ANTIVIRAL RESTRICTION FACTORS
#61COMPOSITIONS AND METHODS FOR TREATING AND AMELIORATING RESPIRATORY CONDITIONS AND INFLAMMATION OF MUCOSA
#62TREATMENT OF SLEEP APNEA WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ALDOSTERONE ANTAGONIST
#63METHODS OF TREATING SMALL CELL LUNG CANCER
#64LIPID-BASED COMPOSITIONS OF ANTIINFECTIVES FOR TREATING PULMONARY INFECTIONS AND METHODS OF USE THEREOF
#65METHOD OF PREVENTING OR TREATING HEART FAILURE IN A PATIENT USING (4S)-4-(4-CYANO-2-METHOXYPHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1,6-NAPHTHYRIDINE-3-CARBOXAMIDE
#66MATERIALS AND METHODS FOR THE MANUFACTURE OF AN ANIMAL FEED
#67TRADITIONAL CHINESE MEDICINE FORMULATION FOR PREVENTING AND TREATING CONSTIPATION-PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-C)
#68USE OF MALE FLOWER EXTRACT OF EUCOMMIA ULMOIDES OLIVER IN PREPARATION OF FOOD OR MEDICAMENT FOR RESISTING MUSCLE AGING
#69COMPOSITION INCLUDING POLYENE ANTIFUNGAL DRUG AND USE THEREOF
#70PROSTANOID RECEPTOR AGONISTS AS NON-TUBERCULOUS ANTI-MYCOBACTERIAL AGENTS
#71HERBAL PREPARATION FOR PREVENTION AND TREATMENT OF HELICOBACTER PYLORI INFECTION
#72DERMAL SKIN PROTECTANT AND CARRIER
#73TISSUE REGENERATIVE MULTI-DRUG COCKTAIL AND APPARATUS FOR DELIVERY THEREOF
#74Selective Modulators of AhR-Regulated Transcription and Method for Using Such Modulators to Treat Cancer
#75PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ALLERGIC DISEASES
#76COMBINATION THERAPY FOR LUNG CANCER
#77Synergistic Herbal Compositions for Pain Management and Opioid Use Reduction
#78PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#79SOLID AND ORAL ETOPOSIDE TONIRIBATE COMPOSITIONS
#80FORMULATION OF AN AMPHOTERICIN B HYBRID AMIDE DERIVATIVE IN DSGPEG2K MICELLES
#81PENTAMIDINE ANALOGS
#82Compositions and Methods for Treating Cancer
#83FLAVONOID-CONTAINING COMPOSITIONS AND TREATMENT OF VIRAL DISEASES WITH SAME
#84Cannabis-Derived Flavonoids And Related Methods
#85ENHANCING AUTOPHAGY OR INCREASING LONGEVITY BY ADMINISTRATION OF UROLITHINS
#86FOLIC ACID-MODIFIED LIPOSOME-ENCAPSULATED TILIANIN NANOCRYSTAL (FA-Lipo@Til NC), PREPARATION METHOD AND USE THEREOF
#87ANTI-MALASSEZIA AGENT
#88COMPOSITIONS FOR SEBUM CONTROL
#89COMBINATION OF SGLT2 INHIBITOR AND MENTHOL AND USE THEREOF IN TREATMENT OF HEART DISEASE
#90METHODS FOR DETECTING ACUTE MYELOID LEUKEMIA
#91COMPOSITIONS AND METHODS FOR IMPROVING SLEEP AND MANAGING STRESS
#92DIETARY SUPPLEMENTS AND METHODS FOR REDUCING INFLAMMATION
#93PHARMACEUTICAL, FOOD, OR FEED COMPOSITION FOR PREVENTING OR TREATING MUSCLE LOSS CONTAINING RHODODENDRON MUCRONULATUM EXTRACT
#94COMPOSITION OF MANGIFERIN AND PROCESS OF PREPARATION THEREOF
#95COMPOSITIONS COMPRISING A COMBINATION OF CAFFEINE AND OLEUROPEIN OR A METABOLITE THEREOF AND THEIR USE FOR IMPROVING MUSCLE FUNCTION
#96Transdermal Delivery Composition for Delivery of at least one Glucose Controlling Agent, and Method of Delivering at least one Glucose Controlling Agent
#97TOPICAL FORMULATIONS
#98COMBINATION SODIUM-GLUCOSE COTRANSPORTER INHIBITOR (SGLTI) INSULIN THERAPY FOR GLYCEMIC CONTROL IN TYPE 1 DIABETES
#99PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#100CANNABINOIDS IN THE TREATMENT OF EPILEPSY
#101ADAPTER FOR USE IN A PLANETARY MIXER
#102COMPOSITIONS AND METHODS FOR NUCLEIC ACID TRANSFER
#103SALTS AND POLYMORPHS OF CETHROMYCIN FOR THE TREATMENT OF DISEASE
#104Olive Tree Polyphenols and Lactobacillus Reuteri Compound for Rebalancing Oral Inflammation and Dysbiosis Associated with Consumers of Tobacco Industry Products
#105COMPOSITIONS AND METHODS USING A COMBINATION OF OLEUROPEIN AND FISETIN FOR CELLULAR ENERGY
#106EZH1/2 DUAL INHIBITOR-CONTAINING PHARMACEUTICAL COMPOSITION TO BE USED AS A COMBINATION DRUG
#107TIMOSAPONIN COMPOUNDS
#108Use of a New Therapeutic Combination to Treat Chronic Venous Insufficiency
#109METHODS OF TREATMENT FOR CYSTIC FIBROSIS
#110METHODS FOR TREATING NOTCH1-DRIVEN CANCERS
#111THERAPY FOR INHIBITION OF SINGLE-STRANDED RNA VIRUS REPLICATION
#112COMPOSITIONS FOR USE IN CARTILAGE BREAKDOWN
#113METHODS FOR TREATING PULMONARY NON-TUBERCULOUS MYCOBACTERIAL INFECTIONS
#114METHODS FOR CONTINUOUS MANUFACTURE OF LIPOSOMAL DRUG PRODUCTS
#115TREATMENT OF TYPE 2 DIABETES MELLITUS
#116COMBINATIONS
#117COMPOSITIONS AND METHODS USING A COMBINATION OF FISETIN AND QUERCETIN FOR CELLULAR ENERGY
#118COMPOSITION FOR IMPROVING UNIDENTIFIED COMPLAINTS, DEPRESSION, IMPAIRED CONCENTRATION, DECREASED MOTIVATION FOR SOCIALIZATION AND DAILY ACTIVITIES, AUTONOMIC NERVOUS SYSTEM DISORDERS, PAIN, CONTROL AND POOR SLEEP QUALITY ASSOCIATED WITH MENSTRUATION.
#119COMPOSITIONS AND METHODS USING A COMBINATION OF FISETIN AND QUERCETIN FOR USE IN CARTILAGE DEGENERATION
#120INDIVIDUALIZED LIFESTYLE INTERVENTION FOR OBESITY MANAGEMENT BASED ON OBESITY PHENOTYPES
#121COMPOSITIONS AND METHODS USING A COMBINATION OF OLEUROPEIN AND FISETIN FOR USE IN CARTILAGE DEGENERATION
#122ANTI-INFLAMMATORY PHYTONUTRIENTS FOR USE IN THE TREATMENT OR PREVENTION OF SYNOVITIS
#123METHOD OF PREVENTING OR TREATING HEART FAILURE IN A PATIENT USING (4S)-4-(4-CYANO-2-METHOXYPHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1,6-NAPHTHYRIDINE-3-CARBOXAMIDE
#124COMPOSITIONS COMPRISING A COMBINATION OF CREATINE AND OLEUROPEIN OR A METABOLITE THEREOF AND THEIR USE FOR IMPROVING MUSCLE FUNCTION
#125SYNTHETIC TRANSDERMAL CANNABIDIOL FOR THE TREATMENT OF FOCAL EPILEPSY IN ADULTS
#126ORAL FORMULATION BASED ON A PRE-ESTABLISHED ASSOCIATION OF SULODEXIDE AND FLAVONOIDS FOR THE TREATMENT OF CHRONIC VENOUS INSUFFICIENCY AND PREVENTION OF COMPLICATIONS THEREOF
#127COMPOSITIONS AND METHODS OF TREATING ACNE AND PHOTOAGING
#128TREATMENT OF A BACTERIAL VAGINAL INFECTION
#129EXTRACELLULAR VESICLES DERIVED FROM MILK AND PROCESS FOR ISOLATING THE SAME
#130COMPOSITIONS AND METHODS USING AT LEAST ONE OF OLEUROPEIN OR A METABOLITE THEREOF TO TREAT OR PREVENT MUSCLE FATIGUE FROM EXERCISE AND/OR FOR RESISTANCE TO MUSCLE FATIGUE FROM EXERCISE
#131GENE THERAPY FOR BLEEDING DISORDERS
#132METHODS AND COMPOSITIONS FOR DETOXIFICATION OF CHRONIC EXPOSURE TO TOXINS
#133TISSUE STORAGE, IRRIGATION, AND INFUSION MEDIUM AND METHODS OF USE
#134PSEUDO-DISACCHARIDE COMPOUNDS
#135METHODS, COMPOSITIONS, AND SYSTEMS FOR DELIVERING THERAPEUTIC AND DIAGNOSTIC AGENTS INTO CELLS
#136COMPOSITIONS AND METHODS FOR TREATING PATIENTS WITH DEMENTIA DUE TO ALZHEIMER'S DISEASE WITH A COMBINATION OF THC AND MELATONIN
#137MEDICATED EYELID CLEANSING COMPOSITIONS
#138PEPTIDE-BASED BIOMARKERS AND RELATED ASPECTS FOR DISEASE DETECTION
#139TOPICAL CREAM AND METHOD OF USE
#140Vaporized Medicants and Methods of Use
#141COMPOSITION FOR PREVENTION AND TREATMENT OF OBESITY OR INSULIN RESISTANCE SYNDROME COMPRISING LACTOBACILLUS PLANTARUM HAC03 AND RUTIN
#142TREATMENT OF METABOLIC DISORDERS IN EQUINE ANIMALS
#143COMPOSITION
#144COMPOSITIONS AND METHODS FOR REDUCING MAJOR THROMBOTIC EVENTS IN CANCER PATIENTS
#145Antibiotic Topical Composition for Absorption into Systemic Bloodstream
#146CRIPTO-POSITIVE LIPID VESICLES FOR USE IN THE THERAPEUTIC TREATMENT OF AGGRESSIVE TUMOURS
#147SOLID FORMS OF AN ALDOSTERONE SYNTHASE INHIBITOR
#148WOUND HEALING DEVICE AND METHODS FOR WOUND HEALING
#149High-Density Nutritional Composition with Plant Polyphenols
#150COMBINATION METABOLIC-EPIGENETIC TREATMENT FOR EARLY LUNG CANCER
#151A TRADITIONAL CHINESE MEDICINE COMPOSITION, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#152COMPOSITION FOR ERADICATING HELICOBACTER PYLORI
#153PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#154REDOX-ACTIVE COMPOUNDS AND RELATED COMPOUNDS, COMPOSITIONS, METHODS AND SYSTEMS
#155ENHANCING AUTOPHAGY OR INCREASING LONGEVITY BY ADMINISTRATION OF UROLITHINS
#156ENHANCING AUTOPHAGY OR INCREASING LONGEVITY BY ADMINISTRATION OF UROLITHINS
#157METHODS OF ADMINISTRATION FOR HIGHLY WATER-SOLUBLE SALTS OF A SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKER
#158PLATFORM DRUG DELIVERY SYSTEM UTILIZING CRYSTAL ENGINEERING AND THEANINE DISSOLUTION
#159METHODS OF USING AVERMECTIN COMPOSITIONS FOR THE TREATMENT OF PAIN AND DOSING REGIMENS
#160METHODS OF USING AVERMECTIN COMPOSITIONS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS AND DOSING REGIMENS
#161PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#162A COMPOSITION COMPRISING LIPID NANOPARTICLES AND AN ANTIFUNGAL POLYENE
#163PREPARATIONS CONTAINING ANTHOCYANINS FOR USE IN THE INFLUENCE OF CARDIOVASCULAR CONDITIONS
#164PHARMACEUTICAL COMPOSITIONS FOR DEMODEX RELATED BLEPHARITIS AND EYELID CRUSTING
#165METHODS AND BIOAVAILABLE HIGHLY PERMEABLE COMPOUNDS FOR THE TREATMENT OF VIRAL DISEASES
#166METHODS AND COMPOSITIONS FOR MEASURING AND INHIBITING EXONUCLEASE ACTIVITY
#167SYNTHETIC TRANSDERMAL CANNABIDIOL FOR THE TREATMENT OF FOCAL EPILEPSY IN ADULTS
#168METHODS AND COMPOSITIONS FOR THE TREATMENT OF STROKE
#169ASPERULOSIDE AS AN AGENT FOR IMPROVING VASCULAR AND METABOLIC FUNCTION IN OBESITY: ROLE OF NRF2 ACTIVATION
#170METHODS OF USING AVERMECTIN COMPOSITIONS FOR THE TREATMENT OF SPASTICITY AND DOSING REGIMENS
#171INACTIVATING BACTERIA WITH ELECTRIC PULSES AND ANTIBIOTICS
#172FLAVONOID ACTIVE FRACTION OF AN ABELMOSCHI COROLLA, PREPARATION METHOD AND APPLICATION THEREOF
#173Use of Genipin-1-B-D-Gentiobioside in Preparation of Drug
#174METHODS OF USING AVERMECTIN COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY DISORDERS AND DOSING REGIMENS
#175LIQUID FORMULATIONS OF IVERMECTIN COMPOSITIONS AND USE IN GELATIN DOSAGE FORMS
#176METHODS OF TREATING ENDOMETRIAL CANCER USING HEMP EXTRACT
#177EXTRACELLULAR VESICLES DERIVED FROM OSTEOBLAST LINEAGE CELLS FOR THERAPEUTIC AND DIAGNOSTIC USE
#178HEATING APPARATUS AND METHODS
#179COMPOSITIONS AND METHODS FOR MODULATING NUCLEAR FACTOR OF ACTIVATED T-CELLS (NFAT) ACTIVITY OF T CELLS
#180METHODS AND COMPOSITIONS FOR TREATING DEMENTIA
#181SAIKOSAPONIN C AS COMPOSITION FOR TREATING OR PREVENTING AGE-RELATED VASCULAR DISEASES INCLUDING ARTERIOSCLEROSIS
#182CARBONIC ANHYDRASE ENZYMES FOR REGULATING MAST CELL HEMATOPOIESIS AND TYPE 2 INFLAMMATION
#183ALPHA 2 ADRENERGIC RECEPTOR BLOCKADE FOR THE TREATMENT OF C. DIFFICILE COLITIS
#184ASSOCIATION WITH ANTIBIOTIC ACTIVITY, PHARMACEUTICAL COMPOSITIONS CONTAINING IT AND THEIR USE IN THE TREATMENT OF INFECTIONS
#185COMBINATION THERAPY USING AZABICYCLO COMPOUND FOR CANCER
#186Compositions And Methods For Inducing Apoptosis In Anaerobic Cells And Related Clinical Methods For Treating Cancer And Pathogenic Infections
#187SALICYLIC ACID COMPOSITIONS AND USES THEREOF
#188PLATINUM-RESISTANT CANCER TREATMENT
#189COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING NEURODEGENERATIVE DISEASES WITH DIABETES
#190ENHANCEMENT OF TUMOR RESPONSE TO CHEMOTHERAPY BY ACTIVATION OF THE ASMASE/CERAMIDE PATHWAY THROUGH TIMED ADMINISTRATION OF A SHORT-ACTING ANTI-ANGIOGENIC AGENT
#191Controlled Release Of A Hydrophilic Agent From A Coated Surface
#192COMBINATION TREATMENT OF AN ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODY AND CHEMOTHERAPY IN CTDNA HIGH RISK PATIENTS
#193COMPOSITIONS AND METHODS FOR SUPPORTING IMMUNE HEALTH
#194HERBAL SUPPLEMENTS AND METHODS OF USE AND MAKING THEREOF
#195LACTIC ACID BACTERIUM-CONTAINING TABLETS
#196SLEEP DISORDER TREATMENT AND PREVENTION
#197METHOD TO INCREASE THE CONCENTRATION OF SHATAVARIN I AND SHATAVARIN IV IN EXTRACT FROM ROOTS
#198COMPOSITION BASED ON PLANT EXTRACTS AND USE THEREOF FOR THE PREVENTION AND/OR TREATMENT OF CARBOHYDRATE AND LIPID DYSMETABOLISM
#199ALCOHOLIC FORMULATION WITH A MIXTURE OF ALKALOIDS, PRENOL LIPIDS AND FLAVONOIDS
#200METHODS AND COMPOSITIONS FOR TREATING CDKL5 DISORDER USING MONOAMINE OXIDASE INHIBITORS
#201METHODS FOR TREATING NEUROBLASTOMA
#202AZITHROMYCIN AND ROXITHROMYCIN DERIVATIVES AS SENOLYTIC DRUGS
#203COMPOSITION FOR CONTROLLING BLOOD SUGAR COMPRISING GALLOCATECHIN GALLATE AND ISOQUERCITRIN
#204COMPOSITION FOR IMPROVING LIVER HEALTH COMPRISING GALLOCATECHIN GALLATE AND ISOQUERCITRIN
#205COMBINATION OF A 4-PYRIMIDINESULFAMIDE DERIVATIVE WITH AN SGLT-2 INHIBITOR FOR THE TREATMENT OF ENDOTHELIN RELATED DISEASES
#206COMPOSITION FOR IMPROVING FATIGUE, EXERCISE PERFORMANCE, OR ENDURANCE COMPRISING GALLOCATECHIN GALLATE AND ISOQUERCITRIN
#207MODIFIED PEPTIDOMIMETICS AND METHODS OF USE
#208PLANT EXTRACT-BASED COMPOSITION AND ITS USE FOR TREATING GLUCOSE METABOLISM DISORDERS
#209METHOD FOR IMPROVING HEALTH CONDITION OF MAMMAL OR FARM ANIMAL
#210ACTIVE PHARMACEUTICAL INGREDIENT COMPOSITIONS AND PREPARATION AND USES THEREOF
#211PHARMACEUTICAL COMPOSITION COMPRISING ENAVOGLIFLOZIN FOR PREVENTING OR TREATING OBESITY IN CANINE ANIMALS
#212ANTI-FUNGALS TARGETING THE SYNTHESIS OF FUNGAL SHINGOLIPIDS
#213LICORICE EXTRACT
#214COMPOSITIONS FOR IMPROVING GUT HEALTH AND/OR MILK PRODUCTION IN RUMINANTS, USES AND METHODS THEREOF
#215MERCAPTOPYRIMIDINE COMPOUNDS THAT INHIBIT NONHOMOLOGOUS END JOINING AND METHODS THEREOF
#216MULTIPLE SIGN BIT HIDING WITHIN A TRANSFORM UNIT
#217TREATMENT FOR CONGESTIVE HEART FAILURE
#218COMBINATION FOR USE FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA, HYPERLIPIDEMIA, CARDIOVASCULAR DISEASE AND METABOLIC SYNDROME
#219BACTERIAL DNA GYRASE INHIBITORS AND METHODS OF USE THEREOF
#220BIOACTIVES AND THEIR USES
#221DERIVATIVES OF TURBINMICIN AS ANTIFUNGAL AGENTS
#222BIOMIMETIC INTRAOCULAR DRUG DELIVERY SYSTEM FOR TREATMENT OF RETINOBLASTOMA AND METHODS THEREOF
#223COMPOSITION FOR PREVENTION AND TREATMENT OF OBESITY AND SARCOPENIA, COMPRISING RHODODENDRON MUCRONULATUM EXTRACT AS ACTIVE INGREDIENT
#224COMPOSITION FOR IMPROVING, PREVENTING, OR TREATING SLEEP DISORDERS COMPRISING DENDROPANAX MORBIFERA EXTRACTS
#225METHODS AND COMPOSITIONS OF TREATING BIOLFILM-RELATED DISEASES
#226Active Ingredient Group For Treating Constipation
#227COMPOSITION, METHOD FOR MICROORGANISM GROWTH SUPPRESSION IN COMPOSITION FOR ORAL USE, AND AGENT FOR POTENTIATION OF MICROORGANISM-GROWTH-SUPPRESSING EFFECT OF QUERCETIN OR GLYCOSIDE THEREOF
#228ADAPTER FOR USE IN A PLANETARY MIXER
#229CORYNEBACTERIUM TO TREAT OR LIMIT CUTANEOUS WOUND INFECTION
#230PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#231STEROIDS AND ANTIBODY-CONJUGATES THEREOF
#232METHOD TO IMPROVE SAFETY AND EFFICACY OF ANTI-CANCER THERAPY
#233COMPOSITION FOR INCREASING MUSCLE STRENGTH CONTAINING COMPLEX EXTRACT OF ANGELICA KEISKEI AND LEAVES OF MORUS ALBA L.
#234Aqueous Composition Comprising Avermectins
#235DRUG DELIVERY SYSTEMS BASED ON ENDOPEROXIDES USEFUL IN DIAGNOSIS AND THERAPY, AND METHODS THEREOF
#236USES OF DPP IV INHIBITORS
#237Heterocyclic Carboxylate Compounds as Glycolate Oxidase Inhibitors
#238DIAGNOSIS AND TREATMENT OF HISTOPLASMOSIS
#239ANTIVIRAL SUPPLEMENT FORMULATIONS FOR HERPESVIRUS INFECTIONS
#240METHODS FOR TREATING PULMONARY NON-TUBERCULOUS MYCOBACTERIAL INFECTIONS
#241ANTIVIRAL USE OF BISEPOXYLIGNAN COMPOUND, AND BISEPOXYLIGNAN COMPOSITION AND PREPARATION OF BISEPOXYLIGNAN COMPOUND
#242USE OF HYPERPOLARIZING AGENTS ALONE AND IN COMBINATION WITH OTHER THERAPEUTIC AGENTS FOR TREATING CANCERS INCLUDING GLIOBLASTOMA
#243P53 PEPTIDOMIMETIC MACROCYCLES
#244SUGAR CANE EXTRACTS FOR USE IN ANIMAL FEEDS
#245WILLOW EXTRACT AND ITS USE IN TREATING A VIRAL INFECTION, ALLERGIC REACTION, AND OTHER MEDICAL CONDITIONS
#246HEAT STRESS RELIEVING AGENT
#247COMBINATION THERAPY FOR TREATMENT OF CANCER
#248USE OF SODIUM FORMATE IN PREPARATION OF AN ANTI-INFECTIVE DRUG
#249ORALLY DISSOLVING ANTIMICROBIAL FILM COMPOSITIONS & METHODS OF THEIR USE
#250COMPOSITIONS AND METHODS FOR THE TREATMENT OF ANTERIOR BLEPHARITIS AND POSTERIOR BLEPHARITIS
#251METHOD AND COMPOSITION FOR PRODUCTION OF A PHYTONUTRIENT IN A MICROBIOME
#252CANCER TREATMENT METHOD USING NANOMEDICINAL COMPOSITION
#253COMPOSITIONS AND METHODS OF CLOSTRIDIODIDES DIFFICILE TREATMENT, DECOLONIZATION, AND PREVENTION
#254ESTIMATION OF BLOOD PRESSURE IN THE HEART
#255GALACTOSIDE DERIVATIVE AS GALECTIN-3 INHIBITOR
#256USE OF A COMBINATION OF LEVOSIMENDAN AND AN SGLT-2 INHIBITOR TO TREAT HEART FAILURE
#257METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS
#258PHARMACEUTICAL COMPOSITION AND A PROCESS TO PREPARE THE SAME
#259Compositions and Methods for Dengue Virus Chimeric Constructions in Vaccines
#260NOVEL TETRAHYDROCURCUMIN COMPOSITIONS, METHODS OF MAKING, AND METHODS OF USING THE SAME
#261COMBINATION THERAPY FOR TREATING LUNG CANCER
#262COMPOSITION OF BEVERAGE CONCENTRATE CONTAINING CITRIC ACID AND NATURAL ANTIOXIDANT
#263ION CHANNEL PROSTHETIC COMPOSITIONS COMPRISING LIPID-COATED CRYSTALS OF AMPHOTERICIN B
#264GENOTYPE-AGNOSTIC RESCUE OF CYSTIC FIBROSIS WITH SMALL MOLECULE BICARBONATE CHANNELS
#265COMPOSITIONS AND METHODS USING A COMBINATION OF OLEUROPEIN AND MAGNESIUM
#266COMPOSITIONS AND METHODS USING A COMBINATION OF OLEUROPEIN AND VITAMIN B6
#267GENOTYPE-AGNOSTIC RESCUE OF CYSTIC FIBROSIS WITH SMALL MOLECULE BICARBONATE CHANNELS
#268COMPOSITE COMPOSITION CONTAINING ANGIOTENSIN RECEPTOR BLOCKER AND SGLT2 INHIBITOR
#269TELODENDRIMER NANOCARRIERS FOR MONOMERIC AMPHOTERICIN B DELIVERY
#270ANTI-TMEFF1 ANTIBODIES AND ANTIBODY DRUG CONJUGATES
#271METHODS FOR TREATMENT OF CANCER WITH AN ANTI-TIGIT ANTAGONIST ANTIBODY
#272METHODS AND COMPOSITIONS FOR PROVIDING MYOCARDIAL PROTECTION AND TREATING MYOCARDIAL STRESS AND FIBROSIS
#273COMPOSITION FOR ALLEVIATING HAIR LOSS AND PROMOTING HAIR GROWTH COMPRISING OAT EXTRACT
#274COMPOSITION FOR PREVENTING OR TREATING MUSCLE DISEASE COMPRISING ARALIA ELATA EXTRACT
#275REMOTE LOADING OF SPARINGLY WATER-SOLUBLE DRUGS INTO LIPID VESICLES
#276USE OF UROLITHIN DERIVATIVES IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS
#277ENCOCHLEATED ANTIFUNGAL COMPOUNDS FOR CENTRAL NERVOUS SYSTEM DELIVERY AND TREATMENT OF CRYPTOCOCCUS INFECTIONS
#278COMPOSITION OF A SWEET CORN SILK EXTRACT FOR MEDICINAL USE AND A METHOD THEREOF
#279COMPOSITIONS AND METHODS FOR IMMUNE HEALTH
#280FORMULATIONS AND METHODS FOR TREATING CONDITIONS OF THE EYE
#281USE OF ISORHOIFOLIN AND DERIVATIVE THEREOF IN PROMOTING NERVE REPAIR
#282TLR7 AGONIST AND COMBINATIONS FOR CANCER TREATMENT
#283METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS
#284ASSESSING AND TREATING MULTIPLE MYELOMA
#285COMPOSITION COMPRISING POLYGALATENOSIDE AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER
#286METHOD FOR TREATING NASAL, SINONASAL, AND NASOPHARYNGEAL TISSUE INFECTION AND/OR INFLAMMATION
#287HIGH DRUG LOADING POLYMERS
#288EXPLOITING IL33 SECRETION AS A THERAPEUTIC TARGET IN CANCER
#289USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREATMENT OF CARDIAC DISEASES IN NON-HUMAN MAMMALS EXCLUDING FELINES, IN PARTICULAR CANINES
#290PHENYLCOUMARINS FOR TREATING INFLAMMATION
#291PROMOTER FOR DIFFERENTIATION INTO CARTILAGE CELL, CARTILAGE CELL PROPAGATION PROMOTER, AND CARTILAGE MATRIX PRODUCTION PROMOTER
#292PHOSPHORYLATED TRISTETRAPROLIN AS A BIOMARKER AND THERAPEUTIC TARGET FOR ANTIAGING DRUGS
#293Combination treatment and/or prevention of renal diseases and/or hypertension in non-human mammals comprising one or more SGLT-2 inhibitors and telmisartan
#294COMPOSITION FOR REDUCING BODY FAT CONTAINING GALLOCATECHIN GALLATE AND ISOQUERCITRIN
#295ODONTOSTOMATOLOGICAL PREPARATION COMPRISING HYALURONIC ACID, ANTIBIOTICS AND GROWTH FACTORS
#296COMPOSITION FOR PREVENTING, AMELIORATING OR TREATING SLEEP DISORDER OR INSOMNIA, CONTAINING EXTRACT OF ROASTED CITRUS BYPRODUCT AS ACTIVE INGREDIENT
#297Cannabinoids C- and O-glycosides possessing anti-proliferative and anti-metastatic properties and process for preparation thereof
#298REGENERATIVE AGENT FOR BONE TISSUE AND LUNG TISSUE, AND PHARMACEUTICAL COMPOSITION FOR REGENERATING BONE TISSUE AND LUNG TISSUE
#299ANDROGEN RECEPTOR BIOMARKERS FOR CANCER THERAPY
#300COMPOSITIONS AND METHODS FOR TREATING LATE STAGE LUNG CANCER